Treatment of shock using adrenomedullin binding protein-1

a technology of adrenomedullin and binding protein, which is applied in the direction of drug composition, peptide/protein ingredients, endocrine system disorders, etc., can solve the problems of difficult identification of one or two, and achieve the effect of reducing preventing or treating the physiologic effect of shock in a mammal
US20050181983A1Inactive Publication Date: 2005-08-18WANG PING
1 Cites 3 Cited by

Patent Information

Authority / Receiving Office
US · United States
Patent Type
Applications(United States)
Current Assignee / Owner
WANG PING
Publication Date
2005-08-18
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

Methods of treating a mammal in shock or at risk for shock are provided. The methods involve administration of an adrenomedullin binding protein-1 to the mammal. Also provided are methods of preventing or treating a physiologic effect of shock in a mammal. These methods also involve administration of an adrenomedullin binding protein-1 to the mammal.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This is a continuation of application Ser. No. 10 / 729,193, filed Dec. 5, 2003, which is a continuation-in-part of application Ser. No. 10 / 439,762, filed May 16, 2003, incorporated by reference in its entirety.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

[0002] The U.S. Government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license others on reasonable terms as provided for by the terms of Grant Nos. RO1 GM57468, GM53008, and KO2 A101461, awarded by the National Institutes of Health.BACKGROUND OF THE INVENTION

[0003] (1) Field of the Invention

[0004] This invention generally relates to treatment of shock. More specifically, the invention is directed to the administration of adrenomedullin binding protein-1 to mammals in shock or at risk for shock.

[0005] (2) Description of the Related Art REFERENCES CITED

[0006] Elsasser T H, Kahl S, Martinez A, Montueng...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More